Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
20k employees
Global biomedical research support for drug development.
HQ
Founded
1947
Founded in Wilmington, Massachusetts, Charles River Laboratories International, Inc. is a global non-clinical contract research organization dedicated to advancing drug discovery and development. The company offers a comprehensive range of services including drug discovery, non-clinical development, and safety testing. Operating through three main segments—Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions—Charles River provides essential support for the biomedical research community worldwide.
Notable figures associated with Charles River Laboratories include key scientists and industry experts who drive innovation within the company. The organization has attracted significant investment from leading healthcare and biotech investors. Key achievements include pioneering advancements in drug safety testing and expanding their global footprint to serve clients in the United States, Europe, Canada, and the Asia Pacific. Overall, Charles River Laboratories has had a profound impact on the biomedical research field, facilitating critical developments in drug discovery and safety assessment.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Drug Development, Safety Testing
Technology
Biotech
Model Types
Professional Services
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Small Business
Geographic Exposure
Global
When was Charl.Riv.Lab Intl DL- 01 founded?
Charl.Riv.Lab Intl DL- 01 was founded in 1947.
Where is Charl.Riv.Lab Intl DL- 01's headquarters located?
Charl.Riv.Lab Intl DL- 01's headquarters is located in Wilmington, MA, US.
When was Charl.Riv.Lab Intl DL- 01's last funding round?
Charl.Riv.Lab Intl DL- 01's most recent funding round was for $1B (USD) in March 2021.
How many employees does Charl.Riv.Lab Intl DL- 01 have?
Charl.Riv.Lab Intl DL- 01 has 20000 employees as of Feb 6, 2024.
How much has Charl.Riv.Lab Intl DL- 01 raised to-date?
As of July 05, 2023, Charl.Riv.Lab Intl DL- 01 has raised a total of $1.5B (USD) since Mar 23, 2021.
Add Comparison
Total Raised to Date
$1.5B
USD
Last Update Mar 23, 2021
Last Deal Details
$1B
USD
Mar 23, 2021
Post Ipo Debt
Current Employees
20k
(over the past year)
Last updated: Feb 6, 2024
Employee Growth Trend
High
Medium
Low
Hover over data points to see confidence level and exact employee count
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts